DNM1L and Alzheimer disease: These studies also suggest that reduced levels of Drp1, VDAC1, CypD and ABAD may inhibit abnormal interactions with Aβ and p-tau and maintain the quality of mitochondria, mitochondrial health and mitophagy in AD [5,31].